FDA Advisory No.2021-0697 || Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for Automatic Renewal Applications for Drug Products

Share this Post!

The FDA, in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices Portal System – an online platform for FDA marketing authorization applications.

The FDA wishes to invite stakeholders to use the FDA eServices Portal System through https://eservices.fda.gov.ph for Automatic Renewal applications. The eServices Portal is in its Pilot Implementation; hence, the scope of the application is limited for the time being:

FDA eServices Portal Pilot Implementation

for Automatic Renewal Applications

Transactions

Automatic Renewal Registration for Regular Certificate of Product Registration (CPR) and Principal Certificate of Product Registration (PCPR)

Automatic Renewal Registration for Certificate of Listing of Identical Drug Product (CLIDP)

Fees to be Paid

Based on Current Issuance on Fees and Charges
(DOH Administrative Order No. 50, s. 2001)

Start of Pilot Implementation

05 April 2021
End of Pilot Implementation

05 May 2021

Please follow Annex A of this Advisory for the Guidelines on Automatic Renewal Applications Using eServices Portal System and Annex B for Procedure on the Use of the FDA eServices Portal System for Automatic Renewal Application.

For comments and suggestions on the FDA eServices Portal, please send them to [email protected].

Attachments